Structured evidence table for Maitake Immune Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Maitake Immune Health Randomized Trial | The bacterial community growths were associated with the production of metabolites over time through GC-MSD analyses such as lactate, butyrate, and propionate. | 4 | De Giani A (2024) | Positive modulation of a new reconstructed human gut microbiota by Maitake extract helpfully boosts the intestinal environment in vitro. |
| Maitake Immune Health Randomized Trial | The human gut is a complex environment where the microbiota and its metabolites play a crucial role in the maintenance of a healthy state. | 4 | De Giani A (2024) | Positive modulation of a new reconstructed human gut microbiota by Maitake extract helpfully boosts the intestinal environment in vitro. |
| Maitake Immune Health Randomized Trial | The aim of the present work is the reconstruction of a new in vitro minimal human gut microbiota resembling the microbe-microbe networking comprising the principal phyla (Bacillota, Bacteroidota, Pseudomonadota, and Actinomycetota), to comprehend the intestinal ecosystem complexity. | 4 | De Giani A (2024) | Positive modulation of a new reconstructed human gut microbiota by Maitake extract helpfully boosts the intestinal environment in vitro. |
| Maitake Immune Health Randomized Trial | The stretch at 1,397 cm-1 is associated with the OH groups in phenolic components. | 4 | Choi Eun-Ju (2023) | Extracts of Grifola frondosa inhibit the MAPK signaling pathways involved in keratinocyte inflammation and ameliorate atopic dermatitis |
| Maitake Immune Health Randomized Trial | The ear thickness of the DFE/DNCB-induced AD and Cera groups was significantly increased (), and images of the mouse ears exhibited pronounced inflammation with erythema and scaling (). | 4 | Choi Eun-Ju (2023) | Extracts of Grifola frondosa inhibit the MAPK signaling pathways involved in keratinocyte inflammation and ameliorate atopic dermatitis |
| Maitake Immune Health Randomized Trial | frondosa suppressed AD-like skin lesions by inhibiting the production of inflammatory cytokines associated with Th1, Th2, Th17, and Th22 responses 16 17 13 18 Fig. | 4 | Choi Eun-Ju (2023) | Extracts of Grifola frondosa inhibit the MAPK signaling pathways involved in keratinocyte inflammation and ameliorate atopic dermatitis |
| Maitake Immune Health Randomized Trial | 1 1 2 Atopic dermatitis (AD) stands as the most prevalent long-term skin inflammation disorder globally. | 4 | Choi Eun-Ju (2023) | Extracts of Grifola frondosa inhibit the MAPK signaling pathways involved in keratinocyte inflammation and ameliorate atopic dermatitis |
Source documents